Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_provenance.
- NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_assertion wasGeneratedBy ECO_0000203 NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_provenance.
- NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_assertion wasDerivedFrom befree-2016 NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_provenance.
- NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_assertion SIO_000772 25066397 NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_provenance.
- NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_assertion evidence source_evidence_literature NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_provenance.
- NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_assertion description "[ITGB3 and BCL-2 increased significantly in A549 cells in CAFs group withβ-actin as control; the expression level of BCL-2 also increased in ITGB3 transfected cells with GFP plasmid transfected A549 cells as control; immunohistochemistry staining showed that positive rates of ITGB3, ITGB1 and BCL-2 in normal lung tissues were 0, the positive rates in lung adenocarcinoma were 7.04%, 84.51% and 4.23%, respectively; in the results of immunohistochemistry staining, the expression of Girdin protein in lung adenocarcinoma was homogeneous, however protein expression of ITGB3, ITGB1 and BCL-2 showed different patterns in the same location with significant heterogeneity; majority of ITGB3, ITGB1 or BCL-2 positive tissue showed heterogeneity that expression in trailing edge was higher than that of trailing edge in lung adenocarcinoma tissue, the patients with BCL-2 heterogeneity showed higher lymph node metastasis ratio and lower clinical stage (P<0.05); and the expression of ITGB3 and the clinical characteristics of patients were not significant related (P>0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1205429.RATzMzPFa0ROwIcZR4Nvn1IpTwDk_SjS1rGaiFtbqqQKw130_provenance.